{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:05:04Z","timestamp":1793088304990,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10103-022-03514-2","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T03:02:14Z","timestamp":1644030134000},"page":"2099-2110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Laser therapy in the treatment of melasma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Dihui","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaona","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"issue":"4","key":"3514_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","volume":"65","author":"VM Sheth","year":"2011","unstructured":"Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part I. J Am Acad Dermatol 65(4):689\u2013697","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3514_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb) 7(3):305\u2013318","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"3514_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","volume":"55","author":"AK Gupta","year":"2006","unstructured":"Gupta AK, Gover MD, Nouri K, Taylor S (2006) The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 55(6):1048\u20131065","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"3514_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.01670.x","volume":"20","author":"JJ Nordlund","year":"2006","unstructured":"Nordlund JJ, Grimes PE, Ortonne JP (2006) The safety of hydroquinone. J Eur Acad Dermatol Venereol 20(7):781\u2013787","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"3514_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TG, Goh CL (2016) Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol 75(2):385\u2013392","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3514_CR6","first-page":"447","volume":"76","author":"R Kumari","year":"2010","unstructured":"Kumari R, Thappa DM (2010) Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol 76(4):447","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"3514_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/14764172.2017.1376098","volume":"20","author":"T Chalermchai","year":"2018","unstructured":"Chalermchai T, Rummaneethorn P (2018) Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma. J Cosmet Laser Ther 20(3):134\u2013139","journal-title":"J Cosmet Laser Ther"},{"issue":"3","key":"3514_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/jdv.15934","volume":"34","author":"YJ Wang","year":"2020","unstructured":"Wang YJ, Lin ET, Chen YT, Chiu PC, Lin BS, Chiang HM, Huang YH, Wang KY, Lin HY, Chang TM et al (2020) Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female Asian patients with melasma. J Eur Acad Dermatol Venereol 34(3):624\u2013632","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"3514_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/lsm.23312","volume":"53","author":"W Manuskiatti","year":"2020","unstructured":"Manuskiatti W, Yan C, Tantrapornpong P, Cembrano KAG, Techapichetvanich T, Wanitphakdeedecha R (2020) A prospective, split-face, randomized study comparing a 755-nm picosecond laser with and without diffractive lens array in the treatment of melasma in Asians. Lasers Surg Med 53(1):95\u2013103","journal-title":"Lasers Surg Med"},{"issue":"8","key":"3514_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/DSS.0000000000000065","volume":"40","author":"AE Moubasher","year":"2014","unstructured":"Moubasher AE, Youssef EM, Abou-Taleb DA (2014) Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Dermatol Surg 40(8):874\u2013882","journal-title":"Dermatol Surg"},{"issue":"1","key":"3514_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1524-4725.2009.01383.x","volume":"36","author":"P Wattanakrai","year":"2010","unstructured":"Wattanakrai P, Mornchan R, Eimpunth S (2010) Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 36(1):76\u201387","journal-title":"Dermatol Surg"},{"issue":"7","key":"3514_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/jdv.12854","volume":"29","author":"V Vachiramon","year":"2015","unstructured":"Vachiramon V, Sirithanabadeekul P, Sahawatwong S (2015) Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol 29(7):1339\u20131346","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"3514_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/14764172.2013.769274","volume":"15","author":"HS Kim","year":"2013","unstructured":"Kim HS, Kim EK, Jung KE, Park YM, Kim HO, Lee JY (2013) A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. J Cosmet Laser Ther 15(3):143\u2013149","journal-title":"J Cosmet Laser Ther"},{"key":"3514_CR14","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Bmj 339:b2535","journal-title":"Bmj"},{"key":"3514_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj 343:d5928","journal-title":"Bmj"},{"issue":"2","key":"3514_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1469-0691.12494","volume":"20","author":"WG Melsen","year":"2014","unstructured":"Melsen WG, Bootsma MC, Rovers MM, Bonten MJ (2014) The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect 20(2):123\u2013129","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3514_CR17","first-page":"315","volume":"9","author":"MA Trelles","year":"2010","unstructured":"Trelles MA, Velez M, Gold MH (2010) The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study. J Drugs Dermatol 9(4):315\u2013322","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"3514_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jaad.2010.01.048","volume":"64","author":"MW Kroon","year":"2011","unstructured":"Kroon MW, Wind BS, Beek JF, van der Veen JP, Nieuweboer-Krobotov\u00e1 L, Bos JD, Wolkerstorfer A (2011) Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol 64(3):516\u2013523","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3514_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1365-2230.2011.04150.x","volume":"36","author":"KY Park","year":"2011","unstructured":"Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK (2011) A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clin Exp Dermatol 36(8):864\u2013870","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"3514_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/14764172.2012.655287","volume":"14","author":"SP Hong","year":"2012","unstructured":"Hong SP, Han SS, Choi SJ, Kim MS, Won CH, Lee MW, Choi JH, Moon KC, Kim YJ, Chang SE (2012) Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. J Cosmet Laser Ther 14(2):81\u201386","journal-title":"J Cosmet Laser Ther"},{"issue":"2","key":"3514_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/0378-6323.93633","volume":"78","author":"HK Kar","year":"2012","unstructured":"Kar HK, Gupta L, Chauhan A (2012) A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma. Indian J Dermatol Venereol Leprol 78(2):165\u2013171","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3 Pt 1","key":"3514_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/dsu.12060","volume":"39","author":"JU Shin","year":"2013","unstructured":"Shin JU, Park J, Oh SH, Lee JH (2013) Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Dermatol Surg 39(3 Pt 1):435\u2013442","journal-title":"Dermatol Surg"},{"issue":"4","key":"3514_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40257-014-0080-x","volume":"15","author":"NY Jalaly","year":"2014","unstructured":"Jalaly NY, Valizadeh N, Barikbin B, Yousefi M (2014) Low-power fractional CO2 laser versus low-fluence Q-switch 1,064 nm Nd: YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol 15(4):357\u2013363","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"3514_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3109\/14764172.2013.864201","volume":"16","author":"DB Lee","year":"2014","unstructured":"Lee DB, Suh HS, Choi YS (2014) A comparative study of low-fluence 1,064nm Q-Switched Nd: YAG laser with or without chemical peeling using Jessner\u2019s solution in melasma patients. J Cosmet Laser Ther 16(6):264\u2013270","journal-title":"J Cosmet Laser Ther"},{"issue":"7","key":"3514_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/14764172.2017.1342036","volume":"19","author":"P Ustuner","year":"2017","unstructured":"Ustuner P, Balevi A, Ozdemir M (2017) A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. J Cosmet Laser Ther 19(7):383\u2013390","journal-title":"J Cosmet Laser Ther"},{"issue":"1","key":"3514_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5021\/ad.2018.30.1.1","volume":"30","author":"SH Kong","year":"2018","unstructured":"Kong SH, Suh HS, Choi YS (2018) Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd: YAG laser: a split-face study. Ann Dermatol 30(1):1\u20137","journal-title":"Ann Dermatol"},{"issue":"5","key":"3514_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14764172.2019.1605447","volume":"21","author":"S Garg","year":"2019","unstructured":"Garg S, Vashisht KR, Makadia S (2019) A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature. J Cosmet Laser Ther 21(5):297\u2013307","journal-title":"J Cosmet Laser Ther"},{"issue":"8","key":"3514_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/DSS.0000000000000057","volume":"40","author":"WJ Yun","year":"2014","unstructured":"Yun WJ, Moon HR, Lee MW, Choi JH, Chang SE (2014) Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial. Dermatol Surg 40(8):842\u2013850","journal-title":"Dermatol Surg"},{"key":"3514_CR29","doi-asserted-by":"publisher","unstructured":"Zamanian A, Behrangi E, Hossein Ghafarpour G, Mehran G, Espahbodi R, Hoseinzade Fakhim T, Azizian Z (2015) Effect of hydroquinone plus neodymium-doped yttrium aluminium garnet laser with and without CO2 fractional laser on resistant dermal melasma. J Skin Stem Cell 2(2). https:\/\/doi.org\/10.17795\/jssc30290","DOI":"10.17795\/jssc30290"},{"issue":"12","key":"3514_CR30","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/ijd.15229","volume":"59","author":"T Dev","year":"2020","unstructured":"Dev T, Sreenivas V, Sharma VK, Sahni K, Bhari N, Sethuraman G (2020) A split face randomized controlled trial comparing 1,064 nm Q-switched Nd-YAG laser and modified Kligman\u2019s formulation in patients with melasma in darker skin. Int J Dermatol 59(12):1525\u20131530","journal-title":"Int J Dermatol"},{"issue":"4","key":"3514_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/jocd.13992","volume":"20","author":"Y Qu","year":"2021","unstructured":"Qu Y, Wang F, Liu J, Xia X (2021) Clinical observation and dermoscopy evaluation of fractional CO(2) laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol 20(4):1110\u20131116","journal-title":"J Cosmet Dermatol"},{"key":"3514_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/CCID.S147413","volume":"11","author":"AM Badawi","year":"2018","unstructured":"Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13\u201320","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"3514_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/14764172.2018.1427869","volume":"20","author":"V Laothaworn","year":"2018","unstructured":"Laothaworn V, Juntongjin P (2018) Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. J Cosmet Laser Ther 20(6):320\u2013325","journal-title":"J Cosmet Laser Ther"},{"issue":"9","key":"3514_CR34","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/DSS.0000000000001120","volume":"43","author":"C Kaminaka","year":"2017","unstructured":"Kaminaka C, Furukawa F, Yamamoto Y (2017) The clinical and histological effect of a low-fluence Q-switched 1,064-nm neodymium: yttrium-aluminum-garnet laser for the treatment of melasma and solar lentigenes in Asians: prospective, randomized, and split-face comparative study. Dermatol Surg 43(9):1120\u20131133","journal-title":"Dermatol Surg"},{"issue":"3","key":"3514_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14764170802179687","volume":"10","author":"N Polnikorn","year":"2008","unstructured":"Polnikorn N (2008) Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther 10(3):167\u2013173","journal-title":"J Cosmet Laser Ther"},{"issue":"4","key":"3514_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/jocd.12253","volume":"15","author":"H Gokalp","year":"2016","unstructured":"Gokalp H, Akkaya AD, Oram Y (2016) Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: is it effective? J Cosmet Dermatol 15(4):420\u2013426","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"3514_CR37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/j.1524-4725.2010.01621.x","volume":"36","author":"TM Katz","year":"2010","unstructured":"Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM (2010) Treatment of melasma using fractional photothermolysis: a report of eight cases with long-term follow-up. Dermatol Surg 36(8):1273\u20131280","journal-title":"Dermatol Surg"},{"issue":"12","key":"3514_CR38","first-page":"1645","volume":"31","author":"CK Rokhsar","year":"2005","unstructured":"Rokhsar CK, Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 31(12):1645\u20131650","journal-title":"Dermatol Surg"},{"issue":"6","key":"3514_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/14764172.2010.538412","volume":"12","author":"MR Neeley","year":"2010","unstructured":"Neeley MR, Pearce FB, Collawn SS (2010) Successful treatment of malar dermal melasma with a fractional ablative CO2 laser in a patient with type V skin. J Cosmet Laser Ther 12(6):258\u2013260","journal-title":"J Cosmet Laser Ther"},{"issue":"3","key":"3514_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/lsm.20310","volume":"38","author":"RG Geronemus","year":"2006","unstructured":"Geronemus RG (2006) Fractional photothermolysis: current and future applications. Lasers Surg Med 38(3):169\u2013176","journal-title":"Lasers Surg Med"},{"issue":"1","key":"3514_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/lsm.23244","volume":"53","author":"DC Wu","year":"2021","unstructured":"Wu DC, Goldman MP, Wat H, Chan HHL (2021) A systematic review of picosecond laser in dermatology: evidence and recommendations. Lasers Surg Med 53(1):9\u201349","journal-title":"Lasers Surg Med"},{"issue":"10","key":"3514_CR42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/lsm.22735","volume":"49","author":"YJ Choi","year":"2017","unstructured":"Choi YJ, Nam JH, Kim JY, Min JH, Park KY, Ko EJ, Kim BJ, Kim WS (2017) Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Lasers Surg Med 49(10):899\u2013907","journal-title":"Lasers Surg Med"},{"issue":"11","key":"3514_CR43","first-page":"1104","volume":"18","author":"AB Lyons","year":"2019","unstructured":"Lyons AB, Moy RL, Herrmann JL (2019) A randomized, controlled, split-face study of the efficacy of a picosecond laser in the treatment of melasma. J Drugs Dermatol 18(11):1104\u20131107","journal-title":"J Drugs Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-022-03514-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T09:07:51Z","timestamp":1653728871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-022-03514-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3514"],"URL":"https:\/\/doi.org\/10.1007\/s10103-022-03514-2","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}